The idiopathic intracranial hypertension prospective cohort study: evaluation of prognostic factors and outcomes
-
Published:2022-10-15
Issue:2
Volume:270
Page:851-863
-
ISSN:0340-5354
-
Container-title:Journal of Neurology
-
language:en
-
Short-container-title:J Neurol
Author:
Thaller MarkORCID, Homer VictoriaORCID, Hyder Yousef, Yiangou AndreasORCID, Liczkowski Anthony, Fong Anthony W.ORCID, Virdee JasvirORCID, Piccus Rachel, Roque MarianneORCID, Mollan Susan P.ORCID, Sinclair Alexandra J.ORCID
Abstract
Abstract
Background
There are limited longitudinal data evaluating outcomes in idiopathic intracranial hypertension (IIH). We aimed to evaluate the long-term outcomes in a real-world cohort of patients with IIH and sought to establish the prognostic factors.
Methods
A longitudinal prospective cohort study was conducted over 9 years (2012–2021). Data included demographics and disease status. All consenting patients with IIH were recruited. Visual outcomes included visual acuity, Humphrey visual field and optical coherence tomography (OCT) imaging measurements. Headache frequency, severity, and impact were noted. We analysed the key variables impacting visual and headache outcomes.
Results
The cohort contained 490 patients with a confirmed IIH diagnosis. 98% were female with a mean body mass index (BMI) of 38 kg/m2. Those with the highest OCT retinal nerve fibre layer had the worst visual outcomes. We noted a delayed decline, in the visual field and OCT ganglion cell layer after 12 months. In the medically managed cohort (n = 426), we found that disease duration and change in BMI had the greatest influence on visual outcomes. There was a high burden of headache, with a daily headache at presentation and prior migraine history influencing long-term headache prognosis.
Conclusions
There is a delayed decline in visual outcomes in those with the most severe papilloedema. Disease duration and change in BMI were the key visual prognostic factors, therefore those with the more acute disease may require closer monitoring. Improving prognosis in IIH should focus on the potentially modifiable factor of weight management.
Funder
Healthcare Quality Improvement Partnership IIHUK registered patient charity Association of British Neurologists and Guarantors of the Brain for a 3-year Clinical Research Training Fellowship Medical Research Council National Institute of Health Research Sir Jules Thorn Charitable Trust
Publisher
Springer Science and Business Media LLC
Subject
Neurology (clinical),Neurology
Reference52 articles.
1. Westgate CSJ, Botfield HF, Alimajstorovic Z, Yiangou A, Walsh M, Smith G, Singhal R, Mitchell JL, Grech O, Markey KA, Hebenstreit D, Tennant DA, Tomlinson JW, Mollan SP, Ludwig C, Akerman I, Lavery GG, Sinclair AJ (2021) Systemic and adipocyte transcriptional and metabolic dysregulation in Idiopathic Intracranial Hypertension. JCI Insight 6:e145346 2. Mollan SP, Grech O, Alimajstorovic Z, Wakerley BR, Sinclair AJ (2020) New horizons for idiopathic intracranial hypertension: advances and challenges. Br Med Bull 136:118–126 3. Mollan SP, Tahrani AA, Sinclair AJ (2021) The potentially modifiable risk factor in idiopathic intracranial hypertension: body weight. Neurol Clin Pract. https://doi.org/10.1212/CPJ.0000000000001063 4. Grech O, Clouter A, Mitchell JL, Alimajstorovic Z, Ottridge RS, Yiangou A, Roque M, Tahrani AA, Nicholls M, Taylor AE, Shaheen F, Arlt W, Lavery GG, Shapiro K, Mollan SP, Sinclair AJ (2021) Cognitive performance in idiopathic intracranial hypertension and relevance of intracranial pressure. Brain Commun 3:fcab202 5. Mollan SP, Davies B, Silver NC, Shaw S, Mallucci CL, Wakerley BR, Krishnan A, Chavda SV, Ramalingam S, Edwards J, Hemmings K, Williamson M, Burdon MA, Hassan-Smith G, Digre K, Liu GT, Jensen RH, Sinclair AJ (2018) Idiopathic intracranial hypertension: consensus guidelines on management. J Neurol Neurosurg Psychiatry 89:1088–1100
Cited by
33 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
|
|